EMAIL DETAILS

Hey guys,


We need to think about this as a hypothetical assuming we are owners of the
company via an investment. Therefore, without any regulatory restrictions,
what could/would we do to help our company be successful in NYS. We'd just
need to layout the approach that we'd take on how we'd help try and get to a
satisfactory result for this particular use case. We would not have to do
anything at this point.


Best,


Neil


Neil Callahan

Rosemont Seneca Partners

401 Greenwich Street, Suite 400

New York, New York 10013

212-796-4037 (o)

917-945-9516 (m)

866-749-8879 (f)


Confidentiality Warning: This e-mail contains information intended only for
the use of the individual or entity named above. If the reader of this
e-mail is not the intended recipient or the employee or agent responsible
for delivering it to the intended recipient, any dissemination, publication
or copying of this e-mail is strictly prohibited. The sender does not accept
any responsibility for any loss, disruption or damage to your data or
computer system that may occur while using data contained in, or transmitted
with, this e-mail.If you have received this e-mail in error, please
immediately notify us by return e-mail. Thank you


From: Eric Schwerin [mailto:eschwerin@rosemontseneca.com]
Sent: Friday, November 04, 2011 9:29 AM
To: abusch@rosemontseneca.com
Cc: John DeLoche; Hunter Biden; Devon Archer; Rob Walker; Neil Callahan
Subject: Re: Input needed


Yes, unfortunately, Hunter, Rob and I are all in the air for much of the day
today. That said, my initial thoughts are that this would be a heavy lift
for us. I did a quick google search on Dr. Shah there were no immediate
avenues to him that became apparent based on his bio and prior experience.
I also don't think any of us have any expertise in the NY approval process
or know whether getting in front of him would even be helpful. I think we'd
need to make a few phone calls and see what we can learn about this. That
said, let us think more about it and John maybe I can call you a little
later this afternoon between flights.


Eric D. Schwerin

Rosemont Seneca Partners, LLC

1010 Wisconsin Ave., NW

Suite 705

Washington, DC 20007

(202) 333-1880

eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>

P Consider the environment before printing this email.


On Nov 4, 2011, at 9:04 AM, Arlene Busch wrote:


John,
Hunter, Eric, and I am all out of the office today traveling. I can't speak
for the two of them, but I can not do a call today. I am available on
Monday.

Arlene

Arlene Busch
202-333-1880
Abusch@rosemontseneca.com

_____

From: John DeLoche <jdeloche@rosemontseneca.com>

Date: Thu, 3 Nov 2011 20:28:12 -0700

To: Hunter Biden<hbiden@rosemontseneca.com>; Devon
Archer<darcher@rosemontcapital.com>; Eric
Schwerin<eschwerin@rosemontseneca.com>; Rob
Walker<rwalker@rosemontseneca.com>; Arlene Busch<abusch@rosemontseneca.com>;
Neil Callahan<ncallahan@rosemontseneca.com>

Subject: Input needed


Hi All,


Founder's Fund completed its $12mm investment in Counsyl today.


I had a call with Counsyl management this evening and they asked if we could
be helpful with regulatory channels in NY. Specifically, their lab and test
have been approved in 49 states at this point and their lab has been
approved by the State of New York, however the test itself is still in in
the approval process in NY. NY and CA are two states which require separate
lab approval and individual test approval. Counsyl has been told that NY's
genetic test approval timing is currently as long as 12 months given current
backlog. Specifically, they want us to help them with a roadmap for who we
would help them contact at the NY State government level that could help
them with this process. One idea discussed, which may or may not be the
right one, would be to see if we can get them in front of or on a call with
Dr. Nirav Shah, a Governor Cuomo appointee, who is the Commissioner for the
NY State Sept of Health. The message would be that Counyl's test is the
highest standard of care for expecting parents and it is currently approved
in 49 states but not New York.


I'd appreciate it if we could have a call to discuss. They are looking for
high level feedback, and potentially a call with us on this subject, by
Monday.


Thanks,


John


--
John DeLoche

Managing Director

Rosemont Seneca Technology Partners

One Market, Spear Tower, 36th Floor

San Francisco, CA 94105

office: 415 293 8147 <tel:415%20293%208147>

mobile: 415 793 7070 <tel:415%20793%207070>


This email communication is privileged and confidential and is intended only
for the individuals or entities named above. Any unauthorized dissemination
of any of the contents of this email is strictly prohibited. If you are not
the intended recipient, please do not read, copy, use or disclose to others
the contents of this communication. Please notify the sender that you have
received this e-mail in error and then delete the e-mail.